|
Volumn 8, Issue 1, 2002, Pages 35-40
|
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
4 (N HYDROXYAMINO)ISOBUTYLMETHYLSUCCINYLPHENYLGLYCINE N METHYLAMIDE;
DISINTEGRIN;
G PROTEIN COUPLED RECEPTOR;
HEPARIN BINDING EPIDERMAL GROWTH FACTOR;
KB R 7785;
METALLOPROTEINASE;
METALLOPROTEINASE 12;
METALLOPROTEINASE INHIBITOR;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CONTROLLED STUDY;
DRUG ACTIVITY;
ENZYME INHIBITION;
HEART HYPERTROPHY;
MALE;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN PROCESSING;
RAT;
SIGNAL TRANSDUCTION;
TRANSACTIVATION;
ADAM PROTEINS;
ANGIOTENSIN II;
ANIMALS;
AORTA, THORACIC;
CARDIOMEGALY;
DISEASE MODELS, ANIMAL;
DISINTEGRINS;
EPIDERMAL GROWTH FACTOR;
GLYCINE;
GTP-BINDING PROTEINS;
HEART VENTRICLES;
HYDROXAMIC ACIDS;
HYPERTENSION;
MALE;
MEMBRANE PROTEINS;
METALLOENDOPEPTIDASES;
PHENYLEPHRINE;
PROTEASE INHIBITORS;
PROTEIN PROCESSING, POST-TRANSLATIONAL;
RATS;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
SIGNAL TRANSDUCTION;
SYSTOLE;
TRANS-ACTIVATION (GENETICS);
ANIMALIA;
|
EID: 0036152858
PISSN: 10788956
EISSN: None
Source Type: Journal
DOI: 10.1038/nm0102-35 Document Type: Article |
Times cited : (654)
|
References (22)
|